Vitrobio Pharma is a French pharmaceutical laboratory located in Issoire (Auvergne region, France) and specialized in R&D of polymeric medical devices. The laboratory develops and manufactures different products for the treatment of chronic diseases (Allergies, ENT conditions, dermatology) involving multiple proteins. Vitrobio’s patented technology is based on using natural polymers such as tannins or synthetic, with a strong affinity for disease-specific proteins, as a new type of drug to block multiple proteins simultaneously, offering an effective multitarget treatment. Our latest research has focused on the development of a new concept for slow release-long acting filmogen essential oils called AyurEssentiel. This patented innovation aims to progressively release the active compounds of the oils, thus prolonging their action and increasing their effectiveness. Each formulation contains filmogen glycerol and essential oils. Once applied, the product forms a film which slowly disintegrates through osmotic action, allowing progressive liberation of essential oils and limiting their evaporation.
View Top Employees from Vitrobio PharmaWebsite | http://www.vitrobio.com/ |
Revenue | $5.2 million |
Employees | 25 (25 on RocketReach) |
Founded | 1994 |
Address | Zac De Lavaur, Issoire 63500, FR |
Phone | +33 4 73 55 05 05 |
Industry | Health, Wellness and Fitness, Manufacturing General, Manufacturing |
Web Rank | 14 Million |
Keywords | Vitro Bio France, Alchemilla Vulgaris In Glycerine |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies |
Looking for a particular Vitrobio Pharma employee's phone or email?
The Vitrobio Pharma annual revenue was $5.2 million in 2024.
Ravi Shrivastava is the President of Vitrobio Pharma.
25 people are employed at Vitrobio Pharma.
The NAICS codes for Vitrobio Pharma are [325, 3254, 32, 32541].
The SIC codes for Vitrobio Pharma are [283, 28].